Clinical Trial Update: Phase II Dasatinib Study in Advanced Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase II study evaluating dasatinib in patients with advanced breast cancer, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

Sponsor: Duke University | Conditions: Advanced Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-07-17